e-Drug3D 1511 |
VILAZODONE
|
cas 163521-12-8 |
CLASS NERVOUS SYSTEM |
ROUTE (list) ORAL |
ATC code |
PK parameters F 72 PERCENT |
Target TARGET SEROTONIN REUPTAKE PDB Ligand code = YG7 (link to the list of PDB complexes) Download experimental 3D coordinates of YG7 with added hydrogens |
DrugCentral Sodium-dependent serotonin transporter UNIPROT P31645 SLC6A4 5-hydroxytryptamine receptor 1A UNIPROT P08908 HTR1A |
Download SDF file | 2-Benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]- Formula: Calculated chemical properties: MW 441.53 NB_atoms 33 XLogP 4.03 PSA 96.883 NB_HD 3 NB_HA 7 fsp3 0.31 Lipinski(0=no;1=yes) 1 |
FDA NDA 022567 (label) INN (VILAZODONE HYDROCHLORIDE) VIIBRYD (ABBVIE) APPROVAL= AP YEAR= 2011 NDA 208212 (pdf not found) INN (VILAZODONE HYDROCHLORIDE) VILAZODONE HYDROCHLORIDE (TEVA PHARMS USA) APPROVAL= AP YEAR= 2019 NDA 208202 (pdf not found) INN (VILAZODONE HYDROCHLORIDE) VILAZODONE HYDROCHLORIDE (ALEMBIC) APPROVAL= AP YEAR= 2020 NDA 208200 (pdf not found) INN (VILAZODONE HYDROCHLORIDE) VILAZODONE HYDROCHLORIDE (INVAGEN PHARMS) APPROVAL= AP YEAR= 2021 NDA 208209 (pdf not found) INN (VILAZODONE HYDROCHLORIDE) VILAZODONE HYDROCHLORIDE (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2021 NDA 208228 (pdf not found) INN (VILAZODONE HYDROCHLORIDE) VILAZODONE HYDROCHLORIDE (APOTEX) APPROVAL= AP YEAR= 2023 |
Other links: |